MUMBAI, India, July 24 -- Intellectual Property India has published a patent application (202621066281 A) filed by Atish Raut; Shivraj Jadhav; Sandip Nighute; Girish Kashid; and Prerana Sharad Pawar on May 26, 2026, for Sustained Release Oral Nano Suspension Composition Comprising Remogliflozin And/Or Pharmaceutically Acceptable Salts Thereof.
Inventors include Atish Raut; Shivraj Jadhav; Sandip Nighute; Girish Kashid; and Prerana Sharad Pawar.
The application for the patent was published on July 17, 2026, under issue no. 29/2026.
Abstract: The present invention discloses a pharmaceutical composition comprising nanosuspension of Remogliflozin and pharmaceutically acceptable salts thereof. The pharmaceutical composition comprises Remogliflozin with Surfactant, sustained release polymer, and solvents. The present invention is provided in the form of sustained release dosage form. The process for preparation of pharmaceutical composition comprising nanosuspension of Remogliflozin is also provided.
Disclaimer: Curated by HT Syndication.
